We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Vaccination newsletter for health professionals and immunisation practitioners.
Data on the real-world efficacy of the COVID-19 vaccines.
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.
A Vaccine Damage Payment is a one-off tax-free payment of £120,000 if you're severely disabled as a result of vaccination against certain diseases - what you'll get, eligibility and applying.
Information for healthcare professionals and the public about the Pfizer/BioNTech's bivalent vaccines
Information for immunisation practitioners and other health professionals.
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
Ground-breaking new cancer treatments have moved a step closer with the signing of a major agreement between the government and BioNTech SE.
Use this service to book a COVID-19 vaccination or manage your appointment.
These documents show the vaccines, product names and packaging to compliment the routine immunisation schedule.
Approval of a change to the licence of Comirnaty COVID-19 vaccine will enable thawing and re-labelling of the vaccine outside of the NHS
MHRA scientific and regulatory advice for COVID-19 vaccine developers
Antimicrobial resistance to Group B Streptococcus (GBS) antibiotics is growing. This puts newborns at risk. VDEC is supporting a new vaccine to cut antibiotic use
UKHSA publishes its annual survey of parents to understand attitudes towards the childhood immunisation programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).